Next Issue
Volume 16, 08
Previous Issue
Volume 16, 11
 
 
cardiovascmed-logo

Journal Browser

Journal Browser
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 16, Issue 12 (12 2013) – 4 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
7 pages, 502 KB  
Communication
ALMANAC 2013: Stable Coronary Heart Disease
by Shahed Islam and Adam Timmis
Cardiovasc. Med. 2013, 16(12), 338; https://doi.org/10.4414/cvm.2013.00195 - 18 Dec 2013
Viewed by 25
Abstract
Epidemiological data from Europe, the USA and elsewhere in the developed world show a steep decline in coronary heart disease (CHD) mortality during the last 40 years [...] Full article
6 pages, 1307 KB  
Communication
11th International Symposium on Mechanisms of Vasodilation October 4–6, 2013, University Hospital Zurich, Switzerland
by Ruth Amstein, Thomas F. Lüscher and Paul M. Vanhoutte
Cardiovasc. Med. 2013, 16(12), 332; https://doi.org/10.4414/cvm.2013.00199 - 18 Dec 2013
Viewed by 33
Abstract
Changes in diameter of large arteries and veins, together with the peripheral resistance offered by the small arteries/arterioles of the microcirculation, a re essential for the regulation of the function of the cardiovascular system [...] Full article
Show Figures

Figure 1

3 pages, 679 KB  
Case Report
Arterial Hypertension Refractory to Renal Denervation, Abdominal Pain and Claudication—Any Coral'ation?
by Diego Arroyo, Florian Dick, Matthias Cavassini, Gabriel Guglielmi, Daniel Hayoz, Dai-Do Do and Stéphane Cook
Cardiovasc. Med. 2013, 16(12), 329; https://doi.org/10.4414/cvm.2013.00198 - 18 Dec 2013
Viewed by 31
Abstract
Coral reef aorta is a rare form of calcifying atherosclerosis typically involving the supraand juxtarenal aorta. Patients classically present with refractory hypertension, intermittent claudication and abdominal angina. The treatment is either surgical via transaortic endarterectomy or through transfemoral endovascular stentgraft placement. Here we [...] Read more.
Coral reef aorta is a rare form of calcifying atherosclerosis typically involving the supraand juxtarenal aorta. Patients classically present with refractory hypertension, intermittent claudication and abdominal angina. The treatment is either surgical via transaortic endarterectomy or through transfemoral endovascular stentgraft placement. Here we describe the case of a 45-year-old female patient infected with human immuno deficiency virus, with resistant hypertension, lower limb and abdominal claudication, who was successfully treated with endovascular stent placement. We further provide a brief overview of the disease characteristics and treatment options. Full article
Show Figures

Figure 1

8 pages, 547 KB  
Article
Procalcitonin As A Prognostic Marker in Non-Infected Critically Ill Cardiovascular Patients
by Judith Koning, Simon Ritter and Marco Maggiorini
Cardiovasc. Med. 2013, 16(12), 321; https://doi.org/10.4414/cvm.2013.00197 - 18 Dec 2013
Viewed by 40
Abstract
Background: Procalcitonin (PCT) is a marker of inflammation in systemic bacterial infections. The aim of this study was to determine the role of PCT as a prognostic marker in cardiovascular intensive care unit (ICU) patients with non-infectious conditions.
Methods: 253 critically [...] Read more.
Background: Procalcitonin (PCT) is a marker of inflammation in systemic bacterial infections. The aim of this study was to determine the role of PCT as a prognostic marker in cardiovascular intensive care unit (ICU) patients with non-infectious conditions.
Methods: 253 critically ill medical patients were consecutively included during a 4-month period. The highest PCT plasma level during the first 72 hours of ICU stay was taken for analysis, and a level ≥0.5 ng/ml was defined as elevated. Hospital mortality rates stratified by PCT level were compared among the patients without an infection at ICU admission (n = 223) and among a subgroup of non-infected patients with a cardio vascular diagnosis (n = 164).
Results: The non-infected patients with an elevated PCT level had a 38% mortality rate (15/40), whereas a 9% mortality rate was observed among the non-infected patients with a normal PCT (16/183) (p <0.001). The mortality rate was 42% among the subgroup of cardio vascular patients with an elevated PCT level (11/26), whereas it was 4% among the cardiovascular patients with a normal PCT (6/138) (p <0.001). For PCT, the area under the receiver operating characteristic curve for the prediction of mortality was 0.81 (95% confidence interval [CI] 0.74−0.89) in all non-infected patients and 0.90 (95% CI 0.84−0.96) in the cardiovascular subgroup.
Conclusions: In apparently non-infected critically ill medical patients, particularly in cardiovascular patients, elevated PCT plasma levels are associated with an increased hospital mortality. Nevertheless, PCT values should be interpreted carefully in the clinical context. Full article
Show Figures

Figure 1

Previous Issue
Next Issue
Back to TopTop